Evidence map›Paper›PMID 42182558›Full record

ArticleCureus2026

Atypical Hyaluronic Acid-Induced Vascular Occlusion Masked by a Hematoma: Ultrasound-Guided Diagnosis and Management.

Seline Rasheed, Iman Itani

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Seline RasheedDermatology, Syrian Private University, Damascus, SYR.
Iman ItaniDermatology and Aesthetic Medicine, Lueur Aesthetic Clinic, Dubai, ARE.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hyaluronic acid (HA) fillers are widely used in aesthetic practice as they are generally considered safe and effective. However, vascular occlusions remain a rare but serious complication that can cause tissue ischemia and necrosis if they are missed. Recently, with the challenges of early diagnosis, ultrasound has emerged as a valuable tool in identifying vascular compromise through Doppler flow assessment and visualization of filler deposits, supporting both the diagnosis and management of these events. We present a case of vascular occlusion following HA filler injection to the nasolabial fold and the upper lip, presenting with swelling, blanching, and an atypical, exaggerated hematoma. Initial management at the referring clinic including high-dose hyaluronidase and lidocaine administration was insufficient, followed by the development of a hematoma, which raised the concern for an incomplete resolution of symptoms and complicated accurate assessment of progression and severity. Further evaluation using ultrasound precisely confirmed vascular occlusion of the left angular and left superior labial arteries and guided targeted hyaluronidase administration, allowing for immediate restoration of vascular flow and progressive clinical improvement, resulting in a highly effective approach compared to blind, high-dose treatments. This case highlights the importance of accurately diagnosing vascular occlusions, even when the presentation is not classic. Early recognition and careful monitoring after filler injections are essential to prevent progression and reduce complications. Effective management can significantly improve outcomes, and the use of ultrasound adds a great advantage by improving visualization of vascular structures and enabling more precise and targeted treatments.

Indexed as

filler complicationshematomahyaluronic acid fillerhyaluronidasenasolabial foldultrasound-guidedvascular occlusion

Identifiers

PMID42182558
PMCPMC13198174

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.